The 1 mg dosage strength leads the segment with a 58% share, reflecting its strong acceptance and widespread adoption among healthcare providers and patients
Pradelles, P., Grassi, J., Creminon, C., Boutten, B
43 percent said they said they were buying fewer sugary beverages, and 12 percent said they were buying less alcohol
doi:10.1177/1569186118808217 81. Mostofsky, S
GLP-1 medicationsincluding GLP-1 agonists like semaglutide and dual agonists like tirzepatidework by targeting incretin pathways to reduce hunger, slow digestion, and improve blood sugar regulation
As it travels through the small and large intestines, bacterial enzymes convert bilirubin into stercobilin and urobilin, which give faeces their characteristic brown colour